OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: ...
A new study has uncovered a molecular mechanism by which rice cells perceive viral infections and initiate antiviral response ...
Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...
Bharat Biotech aims to democratize gene therapies, traditionally considered prohibitively expensive and available primarily ...
The Adeno Associated Virus Vector Manufacturing market, valued at USD 1,148.4 million in 2024, is expected to register robust revenue CAGR of 19.6%.Request free copy of this report: March 14, 2025 - ...
The patient underwent treatment in December with Sarepta's therapy, called Elevidys, the company told Reuters in an emailed statement. Elevidys is the only FDA-approved gene therapy for Duchenne ...
Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...
Hyderabad: Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results